HEADER OXIDOREDUCTASE 16-DEC-15 5FRB TITLE CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A TITLE 2 PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TITLE 3 TETRAZOLE-BASED INHIBITOR VT-1598 COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROL 14-ALPHA DEMETHYLASE, CYP51B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 50-519; COMPND 5 EC: 1.14.13.70; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ASPERGILLUS FUMIGATUS; SOURCE 3 ORGANISM_TAXID: 746128; SOURCE 4 GENE: ERG 11; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HMS174; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCW KEYWDS STEROL 14-ALPHA DEMETHYLASE (CYP51), CYTOCHROME P450, HEME, KEYWDS 2 OXIDOREDUCTASE, MONOOXYGENASE, STEROL BIOSYNTHESIS, EUKARYOTIC KEYWDS 3 MEMBRANES, CYTOCHROME P450 FOLD, ENDOPLASMIC RETICULUM MEMBRANE, KEYWDS 4 OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.Y.HARGROVE,Z.WAWRZAK,G.I.LEPESHEVA REVDAT 5 10-JAN-24 5FRB 1 REMARK REVDAT 4 05-JUL-17 5FRB 1 JRNL REVDAT 3 17-MAY-17 5FRB 1 JRNL REVDAT 2 10-MAY-17 5FRB 1 JRNL REVDAT 1 26-APR-17 5FRB 0 JRNL AUTH T.Y.HARGROVE,E.P.GARVEY,W.J.HOEKSTRA,C.M.YATES,Z.WAWRZAK, JRNL AUTH 2 G.RACHAKONDA,F.VILLALTA,G.I.LEPESHEVA JRNL TITL CRYSTAL STRUCTURE OF THE NEW INVESTIGATIONAL DRUG CANDIDATE JRNL TITL 2 VT-1598 IN COMPLEX WITH ASPERGILLUS FUMIGATUS STEROL 14 JRNL TITL 3 ALPHA-DEMETHYLASE PROVIDES INSIGHTS INTO ITS BROAD-SPECTRUM JRNL TITL 4 ANTIFUNGAL ACTIVITY. JRNL REF ANTIMICROB. AGENTS V. 61 2017 JRNL REF 2 CHEMOTHER. JRNL REFN ESSN 1098-6596 JRNL PMID 28461309 JRNL DOI 10.1128/AAC.00570-17 REMARK 2 REMARK 2 RESOLUTION. 2.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0131 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 95.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 11467 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.260 REMARK 3 R VALUE (WORKING SET) : 0.258 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT : 674 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.07 REMARK 3 REFLECTION IN BIN (WORKING SET) : 813 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.3390 REMARK 3 BIN FREE R VALUE SET COUNT : 62 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 116.3 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 153.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.19000 REMARK 3 B22 (A**2) : 0.19000 REMARK 3 B33 (A**2) : -0.61000 REMARK 3 B12 (A**2) : 0.09000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.496 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.523 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 67.354 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3951 ; 0.005 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3700 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5378 ; 0.754 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8523 ; 0.526 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 469 ; 5.799 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 173 ;30.394 ;23.237 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 648 ;14.802 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;14.140 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 573 ; 0.047 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4418 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 936 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1879 ;14.544 ;11.597 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1878 ;14.547 ;11.593 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2347 ;20.414 ;17.457 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2072 ;14.302 ;12.256 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 50 A 580 REMARK 3 ORIGIN FOR THE GROUP (A): 293.3559 16.6827 8.3265 REMARK 3 T TENSOR REMARK 3 T11: 0.4704 T22: 0.1971 REMARK 3 T33: 0.3436 T12: 0.1908 REMARK 3 T13: -0.1167 T23: -0.1747 REMARK 3 L TENSOR REMARK 3 L11: 1.1223 L22: 1.8984 REMARK 3 L33: 0.2513 L12: -0.3911 REMARK 3 L13: 0.0508 L23: -0.5923 REMARK 3 S TENSOR REMARK 3 S11: 0.5967 S12: 0.1397 S13: -0.0702 REMARK 3 S21: -0.2405 S22: -0.3110 S23: 0.7588 REMARK 3 S31: 0.0858 S32: 0.1768 S33: -0.2858 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED REMARK 4 REMARK 4 5FRB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1290065820. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97856 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : BE LENSES DIAMOND LAUE REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12238 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.990 REMARK 200 RESOLUTION RANGE LOW (A) : 95.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.65000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4UHL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.27933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 56.55867 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 56.55867 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.27933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 47 REMARK 465 ALA A 48 REMARK 465 LYS A 49 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 503 CAM VT2 A 590 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A 62 N - CA - C ANGL. DEV. = -18.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 51 -131.77 55.92 REMARK 500 PHE A 61 -8.21 63.73 REMARK 500 LEU A 92 -122.73 53.73 REMARK 500 VAL A 135 -126.80 60.11 REMARK 500 PRO A 240 46.93 -80.85 REMARK 500 SER A 270 -165.49 -116.40 REMARK 500 LYS A 272 -154.69 -115.90 REMARK 500 PRO A 346 159.64 -46.80 REMARK 500 ASN A 415 70.82 48.75 REMARK 500 ALA A 429 112.51 -162.19 REMARK 500 GLU A 433 -164.23 104.74 REMARK 500 ASP A 435 -175.73 -67.83 REMARK 500 LYS A 447 1.67 -67.43 REMARK 500 ASN A 450 -4.98 -52.53 REMARK 500 ARG A 462 155.69 -48.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 273 SER A 274 147.18 REMARK 500 ALA A 432 GLU A 433 137.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 580 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 463 SG REMARK 620 2 HEM A 580 NA 104.0 REMARK 620 3 HEM A 580 NB 86.7 89.3 REMARK 620 4 HEM A 580 NC 76.6 177.4 88.2 REMARK 620 5 HEM A 580 ND 93.1 91.8 178.9 90.7 REMARK 620 6 VT2 A 590 NBA 157.2 96.2 82.8 82.8 97.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 580 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VT2 A 590 DBREF1 5FRB A 48 518 UNP A0A0J5PJX1_ASPFM DBREF2 5FRB A A0A0J5PJX1 48 518 SEQADV 5FRB MET A 47 UNP A0A0J5PJX EXPRESSION TAG SEQADV 5FRB ALA A 48 UNP A0A0J5PJX EXPRESSION TAG SEQADV 5FRB LYS A 49 UNP A0A0J5PJX EXPRESSION TAG SEQADV 5FRB LYS A 50 UNP A0A0J5PJX HIS 50 ENGINEERED MUTATION SEQADV 5FRB THR A 51 UNP A0A0J5PJX GLU 51 ENGINEERED MUTATION SEQADV 5FRB HIS A 519 UNP A0A0J5PJX EXPRESSION TAG SEQRES 1 A 473 MET ALA LYS LYS THR PRO PRO VAL VAL PHE HIS TRP PHE SEQRES 2 A 473 PRO PHE ILE GLY SER THR ILE SER TYR GLY ILE ASP PRO SEQRES 3 A 473 TYR LYS PHE PHE PHE ASP CYS ARG ALA LYS TYR GLY ASP SEQRES 4 A 473 ILE PHE THR PHE ILE LEU LEU GLY LYS LYS THR THR VAL SEQRES 5 A 473 TYR LEU GLY THR LYS GLY ASN ASP PHE ILE LEU ASN GLY SEQRES 6 A 473 LYS LEU ARG ASP VAL CYS ALA GLU GLU VAL TYR SER PRO SEQRES 7 A 473 LEU THR THR PRO VAL PHE GLY ARG HIS VAL VAL TYR ASP SEQRES 8 A 473 CYS PRO ASN ALA LYS LEU MET GLU GLN LYS LYS PHE VAL SEQRES 9 A 473 LYS TYR GLY LEU THR SER ASP ALA LEU ARG SER TYR VAL SEQRES 10 A 473 PRO LEU ILE THR ASP GLU VAL GLU SER PHE VAL LYS ASN SEQRES 11 A 473 SER PRO ALA PHE GLN GLY HIS LYS GLY VAL PHE ASP VAL SEQRES 12 A 473 CYS LYS THR ILE ALA GLU ILE THR ILE TYR THR ALA SER SEQRES 13 A 473 ARG SER LEU GLN GLY LYS GLU VAL ARG SER LYS PHE ASP SEQRES 14 A 473 SER THR PHE ALA GLU LEU TYR HIS ASN LEU ASP MET GLY SEQRES 15 A 473 PHE ALA PRO ILE ASN PHE MET LEU PRO TRP ALA PRO LEU SEQRES 16 A 473 PRO HIS ASN ARG LYS ARG ASP ALA ALA GLN ARG LYS LEU SEQRES 17 A 473 THR GLU THR TYR MET GLU ILE ILE LYS ALA ARG ARG GLN SEQRES 18 A 473 ALA GLY SER LYS LYS ASP SER GLU ASP MET VAL TRP ASN SEQRES 19 A 473 LEU MET SER CYS VAL TYR LYS ASN GLY THR PRO VAL PRO SEQRES 20 A 473 ASP GLU GLU ILE ALA HIS MET MET ILE ALA LEU LEU MET SEQRES 21 A 473 ALA GLY GLN HIS SER SER SER SER THR ALA SER TRP ILE SEQRES 22 A 473 VAL LEU ARG LEU ALA THR ARG PRO ASP ILE MET GLU GLU SEQRES 23 A 473 LEU TYR GLN GLU GLN ILE ARG VAL LEU GLY SER ASP LEU SEQRES 24 A 473 PRO PRO LEU THR TYR ASP ASN LEU GLN LYS LEU ASP LEU SEQRES 25 A 473 HIS ALA LYS VAL ILE LYS GLU THR LEU ARG LEU HIS ALA SEQRES 26 A 473 PRO ILE HIS SER ILE ILE ARG ALA VAL LYS ASN PRO MET SEQRES 27 A 473 ALA VAL ASP GLY THR SER TYR VAL ILE PRO THR SER HIS SEQRES 28 A 473 ASN VAL LEU SER SER PRO GLY VAL THR ALA ARG SER GLU SEQRES 29 A 473 GLU HIS PHE PRO ASN PRO LEU GLU TRP ASN PRO HIS ARG SEQRES 30 A 473 TRP ASP GLU ASN ILE ALA ALA SER ALA GLU ASP ASP GLU SEQRES 31 A 473 LYS VAL ASP TYR GLY TYR GLY LEU VAL SER LYS GLY THR SEQRES 32 A 473 ASN SER PRO TYR LEU PRO PHE GLY ALA GLY ARG HIS ARG SEQRES 33 A 473 CYS ILE GLY GLU GLN PHE ALA TYR LEU GLN LEU GLY THR SEQRES 34 A 473 ILE THR ALA VAL LEU VAL ARG LEU PHE ARG PHE ARG ASN SEQRES 35 A 473 LEU PRO GLY VAL ASP GLY ILE PRO ASP THR ASP TYR SER SEQRES 36 A 473 SER LEU PHE SER LYS PRO LEU GLY ARG SER PHE VAL GLU SEQRES 37 A 473 PHE GLU LYS ARG HIS HET HEM A 580 43 HET VT2 A 590 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM VT2 (R)-4-((4-((6-(2-(2,4-DIFLUOROPHENYL)-1,1-DIFLUORO-2- HETNAM 2 VT2 HYDROXY-3-(1H-TETRAZOL-1-YL)PROPYL)PYRIDIN-3-YL) HETNAM 3 VT2 ETHYNYL)PHENOXY)METHYL)BENZONITRILE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 VT2 C31 H22 F4 N6 O2 HELIX 1 1 SER A 64 ASP A 71 1 8 HELIX 2 2 ASP A 71 GLY A 84 1 14 HELIX 3 3 LEU A 100 ASN A 110 1 11 HELIX 4 4 ALA A 118 GLY A 131 1 14 HELIX 5 5 VAL A 134 CYS A 138 5 5 HELIX 6 6 PRO A 139 GLY A 153 1 15 HELIX 7 7 THR A 155 SER A 177 1 23 HELIX 8 8 PRO A 178 GLN A 181 5 4 HELIX 9 9 VAL A 189 LEU A 205 1 17 HELIX 10 10 GLY A 207 PHE A 214 1 8 HELIX 11 11 PHE A 218 ASP A 226 1 9 HELIX 12 12 MET A 227 PHE A 229 5 3 HELIX 13 13 PRO A 231 LEU A 236 1 6 HELIX 14 14 LEU A 241 GLY A 269 1 29 HELIX 15 15 GLU A 275 SER A 283 1 9 HELIX 16 16 PRO A 293 ARG A 326 1 34 HELIX 17 17 ARG A 326 LEU A 341 1 16 HELIX 18 18 ASP A 357 ALA A 371 1 15 HELIX 19 19 SER A 402 ARG A 408 1 7 HELIX 20 20 ASN A 420 ASN A 427 5 8 HELIX 21 21 ALA A 458 ARG A 462 5 5 HELIX 22 22 GLY A 465 LEU A 483 1 19 SHEET 1 AA 5 ILE A 86 PHE A 89 0 SHEET 2 AA 5 LYS A 95 TYR A 99 -1 O THR A 96 N PHE A 89 SHEET 3 AA 5 HIS A 397 SER A 401 1 O ASN A 398 N THR A 97 SHEET 4 AA 5 ILE A 376 VAL A 380 -1 O ILE A 376 N SER A 401 SHEET 5 AA 5 VAL A 116 CYS A 117 -1 O CYS A 117 N ALA A 379 SHEET 1 AB 3 LYS A 184 ASP A 188 0 SHEET 2 AB 3 PHE A 512 LYS A 517 -1 O VAL A 513 N PHE A 187 SHEET 3 AB 3 PHE A 484 ASN A 488 -1 O ARG A 485 N GLU A 516 SHEET 1 AC 2 MET A 384 ALA A 385 0 SHEET 2 AC 2 VAL A 392 ILE A 393 -1 O ILE A 393 N MET A 384 SHEET 1 AD 2 LYS A 437 VAL A 438 0 SHEET 2 AD 2 VAL A 445 SER A 446 -1 O VAL A 445 N VAL A 438 SHEET 1 AE 2 THR A 498 ASP A 499 0 SHEET 2 AE 2 LYS A 506 PRO A 507 -1 O LYS A 506 N ASP A 499 LINK SG CYS A 463 FE HEM A 580 1555 1555 2.28 LINK FE HEM A 580 NBA VT2 A 590 1555 1555 2.14 SITE 1 AC1 12 TYR A 136 LEU A 143 LYS A 147 LEU A 304 SITE 2 AC1 12 SER A 311 ILE A 376 ARG A 378 PRO A 455 SITE 3 AC1 12 PHE A 456 HIS A 461 CYS A 463 VT2 A 590 SITE 1 AC2 11 GLY A 69 PHE A 130 TYR A 136 ALA A 303 SITE 2 AC2 11 ALA A 307 HIS A 374 TYR A 500 SER A 501 SITE 3 AC2 11 SER A 502 LEU A 503 HEM A 580 CRYST1 109.857 109.857 84.838 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009103 0.005255 0.000000 0.00000 SCALE2 0.000000 0.010511 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011787 0.00000